Medicament for the treatment of choroidal neovascularisation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/00 (2006.01) C07K 16/06 (2006.01)

Patent

CA 2474405

The present invention refers to the use of 7 S immunoglobulin or an active fraction thereof for the manufacture of a medicament for the treatment of choroidal neovascularaisation and a pharmaceutical composition essentially consisting of an active fraction of 7 S immunoglobulin as pharmaceutically active compound and a method for the treatment of chorodial neovascularisation which comprises administering to the patient a preparation of 7 S immunoglobulin

La présente invention concerne l'emploi de l'immunoglobuline 7S ou d'une fraction active de celle-ci dans la fabrication d'un médicament destiné au traitement de la néovascularisation choroïdienne, ainsi qu'une composition pharmaceutique composée essentiellement d'une fraction active d'immunoglobuline 7S en tant que composé pharmaceutique actif, et une méthode de traitement de la néovascularisation choroïdienne consistant à administrer au patient une préparation d'immunoglobuline 7S.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Medicament for the treatment of choroidal neovascularisation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament for the treatment of choroidal neovascularisation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for the treatment of choroidal neovascularisation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1726524

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.